New RealWorld Data Analyses Support the LongTerm Use of Entyvio in BioNave Patients for the Treatment of Moderate to Severe Ulcerative Colitis or Crohns Disease

Deerfield IL October 8 2018Â Takeda Pharmaceuticals U.S.A. Inc. Takeda today announced the presentation of new longterm efficacy realworld data analyses for EntyvioÂÂvedolizumab at ACG 2018 in Philadelphia PA. Studies of note include a retrospective multic...